chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Painful respiration, Pericarditis
Clinical narrative: Diagnosis:  pericarditis.; This is a spontaneous report from a contactable consumer (patient).  A 77-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL9261), via an unspecified route of administration on 28Jan2021 14:15 (at the age of 77-year-old) at single dose on Left arm for COVID-19 immunization.  Medical history included high cholesterol and high blood pressure. No Known allergies. No COVID prior vaccination.  Concomitant medication included rosuvastatin, lisinopril, hctz. No other vaccine in four weeks. The patient experienced mild to moderate chest pain behind sternum when breathing normally, pain worse with heavy breathing, diagnosed as pericarditis on 01Feb2021 02:00, which resulted in Emergency room/department or urgent care, Hospitalization. The patient was hospitalized for pericarditis for 2 days.  The patient underwent lab tests and procedures which included Nasal Swab prc: negative on 02Feb2021.  Therapeutic measures were taken as a result of pericarditis including 1800 mg ibuprofen;colchicine 0.6 mg 2x/day. The event outcome was recovering.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pericarditis, SARS-CoV-2 test
Clinical narrative: Diagnosis:  pericarditis.; This is a spontaneous report from a contactable consumer (patient).  A 77-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL9261), via an unspecified route of administration on 28Jan2021 14:15 (at the age of 77-year-old) at single dose on Left arm for COVID-19 immunization.  Medical history included high cholesterol and high blood pressure. No Known allergies. No COVID prior vaccination.  Concomitant medication included rosuvastatin, lisinopril, hctz. No other vaccine in four weeks. The patient experienced mild to moderate chest pain behind sternum when breathing normally, pain worse with heavy breathing, diagnosed as pericarditis on 01Feb2021 02:00, which resulted in Emergency room/department or urgent care, Hospitalization. The patient was hospitalized for pericarditis for 2 days.  The patient underwent lab tests and procedures which included Nasal Swab prc: negative on 02Feb2021.  Therapeutic measures were taken as a result of pericarditis including 1800 mg ibuprofen;colchicine 0.6 mg 2x/day. The event outcome was recovering.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Body temperature increased, Bradycardia, Chest X-ray, Confusional state
Clinical narrative: Strained breathing/ Strained, labored breathing; Weakness; Slight temperature/ 101.6 F temperature within 1 Hr; Strained breathing/ Strained, labored breathing; Shaking in both arms for 2- 3 Hrs (severe); Fatigue to near incapacitation (severe); Muscular movement unresponsive; Immobility/ Unable to stand, sit up, raise arms; Incontinence; Confusion, non-responsive, fog; Confusion, non-responsive, fog; This is a spontaneous report from a contactable Consumer.    An 85-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EN6198) at single dose at right arm on 20Feb2021 15:30 for Covid-19 immunisation.  Medical history included high blood pressure, no known allergies. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications in two weeks were unspecified. The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EL3249) at single dose on 30Jan2021 15:45 for Covid-19 immunisation, administered at hospital. No other vaccine in 4 weeks. On 20Feb2021 15:45 directly following administration the patient experienced shaking in both arms for 2- 3 hrs (severe, not just mild trembling, unable to hold water), fatigue to near incapacitation (severe) for 4-5 hrs, muscular movement unresponsive, immobility/ unable to stand, sit up, raise arms, incontinence twice after 2 hrs, confusion, non-responsive, fog for 4-5 hrs, slight temperature/ 101.6 f temperature within 1 hr amdc ontinued overnight, strained breathing/ strained, labored breathing, weakness. Events resulted in hospitalization as life threatening illness (immediate risk of death from the event) and received treatment for the events. Hospitalization lasted 3 days. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on 20Feb2021, nasal swab rapid SARS-COV2-RNA screening molecular test: negative on 23Feb2021, Bio Fire Film Array Respiratory Panel 2 (RP2): negative on 23Feb2021. The outcome of shaking in both arms, fatigue to near incapacitation, muscular movement unresponsive, incontinence, confusion, non-responsive, fog was recovering, of immobility/ unable to stand, sit up, raise arms, slight temperature/ 101.6 f temperature, trained breathing/ strained, labored breathing, weakness was not recovered.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyskinesia, Dyspnoea, Dysstasia, Echocardiogram, Fatigue
Clinical narrative: Strained breathing/ Strained, labored breathing; Weakness; Slight temperature/ 101.6 F temperature within 1 Hr; Strained breathing/ Strained, labored breathing; Shaking in both arms for 2- 3 Hrs (severe); Fatigue to near incapacitation (severe); Muscular movement unresponsive; Immobility/ Unable to stand, sit up, raise arms; Incontinence; Confusion, non-responsive, fog; Confusion, non-responsive, fog; This is a spontaneous report from a contactable Consumer.    An 85-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EN6198) at single dose at right arm on 20Feb2021 15:30 for Covid-19 immunisation.  Medical history included high blood pressure, no known allergies. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications in two weeks were unspecified. The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EL3249) at single dose on 30Jan2021 15:45 for Covid-19 immunisation, administered at hospital. No other vaccine in 4 weeks. On 20Feb2021 15:45 directly following administration the patient experienced shaking in both arms for 2- 3 hrs (severe, not just mild trembling, unable to hold water), fatigue to near incapacitation (severe) for 4-5 hrs, muscular movement unresponsive, immobility/ unable to stand, sit up, raise arms, incontinence twice after 2 hrs, confusion, non-responsive, fog for 4-5 hrs, slight temperature/ 101.6 f temperature within 1 hr amdc ontinued overnight, strained breathing/ strained, labored breathing, weakness. Events resulted in hospitalization as life threatening illness (immediate risk of death from the event) and received treatment for the events. Hospitalization lasted 3 days. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on 20Feb2021, nasal swab rapid SARS-COV2-RNA screening molecular test: negative on 23Feb2021, Bio Fire Film Array Respiratory Panel 2 (RP2): negative on 23Feb2021. The outcome of shaking in both arms, fatigue to near incapacitation, muscular movement unresponsive, incontinence, confusion, non-responsive, fog was recovering, of immobility/ unable to stand, sit up, raise arms, slight temperature/ 101.6 f temperature, trained breathing/ strained, labored breathing, weakness was not recovered.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Full blood count, Immediate post-injection reaction, Incontinence, Laboratory test
Clinical narrative: Strained breathing/ Strained, labored breathing; Weakness; Slight temperature/ 101.6 F temperature within 1 Hr; Strained breathing/ Strained, labored breathing; Shaking in both arms for 2- 3 Hrs (severe); Fatigue to near incapacitation (severe); Muscular movement unresponsive; Immobility/ Unable to stand, sit up, raise arms; Incontinence; Confusion, non-responsive, fog; Confusion, non-responsive, fog; This is a spontaneous report from a contactable Consumer.    An 85-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EN6198) at single dose at right arm on 20Feb2021 15:30 for Covid-19 immunisation.  Medical history included high blood pressure, no known allergies. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications in two weeks were unspecified. The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EL3249) at single dose on 30Jan2021 15:45 for Covid-19 immunisation, administered at hospital. No other vaccine in 4 weeks. On 20Feb2021 15:45 directly following administration the patient experienced shaking in both arms for 2- 3 hrs (severe, not just mild trembling, unable to hold water), fatigue to near incapacitation (severe) for 4-5 hrs, muscular movement unresponsive, immobility/ unable to stand, sit up, raise arms, incontinence twice after 2 hrs, confusion, non-responsive, fog for 4-5 hrs, slight temperature/ 101.6 f temperature within 1 hr amdc ontinued overnight, strained breathing/ strained, labored breathing, weakness. Events resulted in hospitalization as life threatening illness (immediate risk of death from the event) and received treatment for the events. Hospitalization lasted 3 days. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on 20Feb2021, nasal swab rapid SARS-COV2-RNA screening molecular test: negative on 23Feb2021, Bio Fire Film Array Respiratory Panel 2 (RP2): negative on 23Feb2021. The outcome of shaking in both arms, fatigue to near incapacitation, muscular movement unresponsive, incontinence, confusion, non-responsive, fog was recovering, of immobility/ unable to stand, sit up, raise arms, slight temperature/ 101.6 f temperature, trained breathing/ strained, labored breathing, weakness was not recovered.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Muscle disorder, Posture abnormal, Tremor, Ultrasound Doppler
Clinical narrative: Strained breathing/ Strained, labored breathing; Weakness; Slight temperature/ 101.6 F temperature within 1 Hr; Strained breathing/ Strained, labored breathing; Shaking in both arms for 2- 3 Hrs (severe); Fatigue to near incapacitation (severe); Muscular movement unresponsive; Immobility/ Unable to stand, sit up, raise arms; Incontinence; Confusion, non-responsive, fog; Confusion, non-responsive, fog; This is a spontaneous report from a contactable Consumer.    An 85-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EN6198) at single dose at right arm on 20Feb2021 15:30 for Covid-19 immunisation.  Medical history included high blood pressure, no known allergies. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications in two weeks were unspecified. The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EL3249) at single dose on 30Jan2021 15:45 for Covid-19 immunisation, administered at hospital. No other vaccine in 4 weeks. On 20Feb2021 15:45 directly following administration the patient experienced shaking in both arms for 2- 3 hrs (severe, not just mild trembling, unable to hold water), fatigue to near incapacitation (severe) for 4-5 hrs, muscular movement unresponsive, immobility/ unable to stand, sit up, raise arms, incontinence twice after 2 hrs, confusion, non-responsive, fog for 4-5 hrs, slight temperature/ 101.6 f temperature within 1 hr amdc ontinued overnight, strained breathing/ strained, labored breathing, weakness. Events resulted in hospitalization as life threatening illness (immediate risk of death from the event) and received treatment for the events. Hospitalization lasted 3 days. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on 20Feb2021, nasal swab rapid SARS-COV2-RNA screening molecular test: negative on 23Feb2021, Bio Fire Film Array Respiratory Panel 2 (RP2): negative on 23Feb2021. The outcome of shaking in both arms, fatigue to near incapacitation, muscular movement unresponsive, incontinence, confusion, non-responsive, fog was recovering, of immobility/ unable to stand, sit up, raise arms, slight temperature/ 101.6 f temperature, trained breathing/ strained, labored breathing, weakness was not recovered.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: Strained breathing/ Strained, labored breathing; Weakness; Slight temperature/ 101.6 F temperature within 1 Hr; Strained breathing/ Strained, labored breathing; Shaking in both arms for 2- 3 Hrs (severe); Fatigue to near incapacitation (severe); Muscular movement unresponsive; Immobility/ Unable to stand, sit up, raise arms; Incontinence; Confusion, non-responsive, fog; Confusion, non-responsive, fog; This is a spontaneous report from a contactable Consumer.    An 85-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EN6198) at single dose at right arm on 20Feb2021 15:30 for Covid-19 immunisation.  Medical history included high blood pressure, no known allergies. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications in two weeks were unspecified. The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EL3249) at single dose on 30Jan2021 15:45 for Covid-19 immunisation, administered at hospital. No other vaccine in 4 weeks. On 20Feb2021 15:45 directly following administration the patient experienced shaking in both arms for 2- 3 hrs (severe, not just mild trembling, unable to hold water), fatigue to near incapacitation (severe) for 4-5 hrs, muscular movement unresponsive, immobility/ unable to stand, sit up, raise arms, incontinence twice after 2 hrs, confusion, non-responsive, fog for 4-5 hrs, slight temperature/ 101.6 f temperature within 1 hr amdc ontinued overnight, strained breathing/ strained, labored breathing, weakness. Events resulted in hospitalization as life threatening illness (immediate risk of death from the event) and received treatment for the events. Hospitalization lasted 3 days. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on 20Feb2021, nasal swab rapid SARS-COV2-RNA screening molecular test: negative on 23Feb2021, Bio Fire Film Array Respiratory Panel 2 (RP2): negative on 23Feb2021. The outcome of shaking in both arms, fatigue to near incapacitation, muscular movement unresponsive, incontinence, confusion, non-responsive, fog was recovering, of immobility/ unable to stand, sit up, raise arms, slight temperature/ 101.6 f temperature, trained breathing/ strained, labored breathing, weakness was not recovered.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Body temperature, Confusional state, Dyspnoea, Fatigue
Clinical narrative: Strained breathing/ Strained, labored breathing; Weakness; Slight temperature/ 101.6 F temperature within 1 Hr; Strained breathing/ Strained, labored breathing; Shaking in both arms for 2- 3 Hrs (severe); Fatigue to near incapacitation (severe); Muscular movement unresponsive; Immobility/ Unable to stand, sit up, raise arms; Incontinence; Confusion, non-responsive, fog; Confusion, non-responsive, fog; This is a spontaneous report from a contactable Consumer.    An 85-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EN6198) at single dose at right arm on 20Feb2021 15:30 for Covid-19 immunisation.  Medical history included high blood pressure, no known allergies. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications in two weeks were unspecified. The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EL3249) at single dose on 30Jan2021 15:45 for Covid-19 immunisation, administered at hospital. No other vaccine in 4 weeks. On 20Feb2021 15:45 directly following administration the patient experienced shaking in both arms for 2- 3 hrs (severe, not just mild trembling, unable to hold water), fatigue to near incapacitation (severe) for 4-5 hrs, muscular movement unresponsive, immobility/ unable to stand, sit up, raise arms, incontinence twice after 2 hrs, confusion, non-responsive, fog for 4-5 hrs, slight temperature/ 101.6 f temperature within 1 hr amdc ontinued overnight, strained breathing/ strained, labored breathing, weakness. Events resulted in hospitalization as life threatening illness (immediate risk of death from the event) and received treatment for the events. Hospitalization lasted 3 days. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on 20Feb2021, nasal swab rapid SARS-COV2-RNA screening molecular test: negative on 23Feb2021, Bio Fire Film Array Respiratory Panel 2 (RP2): negative on 23Feb2021. The outcome of shaking in both arms, fatigue to near incapacitation, muscular movement unresponsive, incontinence, confusion, non-responsive, fog was recovering, of immobility/ unable to stand, sit up, raise arms, slight temperature/ 101.6 f temperature, trained breathing/ strained, labored breathing, weakness was not recovered.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immobile, Incontinence, Investigation, Muscle disorder, Muscle strain
Clinical narrative: Strained breathing/ Strained, labored breathing; Weakness; Slight temperature/ 101.6 F temperature within 1 Hr; Strained breathing/ Strained, labored breathing; Shaking in both arms for 2- 3 Hrs (severe); Fatigue to near incapacitation (severe); Muscular movement unresponsive; Immobility/ Unable to stand, sit up, raise arms; Incontinence; Confusion, non-responsive, fog; Confusion, non-responsive, fog; This is a spontaneous report from a contactable Consumer.    An 85-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EN6198) at single dose at right arm on 20Feb2021 15:30 for Covid-19 immunisation.  Medical history included high blood pressure, no known allergies. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications in two weeks were unspecified. The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EL3249) at single dose on 30Jan2021 15:45 for Covid-19 immunisation, administered at hospital. No other vaccine in 4 weeks. On 20Feb2021 15:45 directly following administration the patient experienced shaking in both arms for 2- 3 hrs (severe, not just mild trembling, unable to hold water), fatigue to near incapacitation (severe) for 4-5 hrs, muscular movement unresponsive, immobility/ unable to stand, sit up, raise arms, incontinence twice after 2 hrs, confusion, non-responsive, fog for 4-5 hrs, slight temperature/ 101.6 f temperature within 1 hr amdc ontinued overnight, strained breathing/ strained, labored breathing, weakness. Events resulted in hospitalization as life threatening illness (immediate risk of death from the event) and received treatment for the events. Hospitalization lasted 3 days. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on 20Feb2021, nasal swab rapid SARS-COV2-RNA screening molecular test: negative on 23Feb2021, Bio Fire Film Array Respiratory Panel 2 (RP2): negative on 23Feb2021. The outcome of shaking in both arms, fatigue to near incapacitation, muscular movement unresponsive, incontinence, confusion, non-responsive, fog was recovering, of immobility/ unable to stand, sit up, raise arms, slight temperature/ 101.6 f temperature, trained breathing/ strained, labored breathing, weakness was not recovered.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, Tremor, Unresponsive to stimuli
Clinical narrative: Strained breathing/ Strained, labored breathing; Weakness; Slight temperature/ 101.6 F temperature within 1 Hr; Strained breathing/ Strained, labored breathing; Shaking in both arms for 2- 3 Hrs (severe); Fatigue to near incapacitation (severe); Muscular movement unresponsive; Immobility/ Unable to stand, sit up, raise arms; Incontinence; Confusion, non-responsive, fog; Confusion, non-responsive, fog; This is a spontaneous report from a contactable Consumer.    An 85-year-old male patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EN6198) at single dose at right arm on 20Feb2021 15:30 for Covid-19 immunisation.  Medical history included high blood pressure, no known allergies. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications in two weeks were unspecified. The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EL3249) at single dose on 30Jan2021 15:45 for Covid-19 immunisation, administered at hospital. No other vaccine in 4 weeks. On 20Feb2021 15:45 directly following administration the patient experienced shaking in both arms for 2- 3 hrs (severe, not just mild trembling, unable to hold water), fatigue to near incapacitation (severe) for 4-5 hrs, muscular movement unresponsive, immobility/ unable to stand, sit up, raise arms, incontinence twice after 2 hrs, confusion, non-responsive, fog for 4-5 hrs, slight temperature/ 101.6 f temperature within 1 hr amdc ontinued overnight, strained breathing/ strained, labored breathing, weakness. Events resulted in hospitalization as life threatening illness (immediate risk of death from the event) and received treatment for the events. Hospitalization lasted 3 days. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on 20Feb2021, nasal swab rapid SARS-COV2-RNA screening molecular test: negative on 23Feb2021, Bio Fire Film Array Respiratory Panel 2 (RP2): negative on 23Feb2021. The outcome of shaking in both arms, fatigue to near incapacitation, muscular movement unresponsive, incontinence, confusion, non-responsive, fog was recovering, of immobility/ unable to stand, sit up, raise arms, slight temperature/ 101.6 f temperature, trained breathing/ strained, labored breathing, weakness was not recovered.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Ear pain, Facial paralysis, Hyperacusis, Lagophthalmos
Clinical narrative: had total paralysis of the left side of his face; This is a spontaneous report from a contactable consumer (Patient). A 61-year-old male patient received 2nd dose of BNT162B2  (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration at arm left on 20Feb2021 11:00 AM at the age of 61-year-old at single dose for COVID-19 immunisation. Patient previously received first dose of BNT162B2  (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration at left arm on 30Jan2021 11:00 AM at the age of 61-year-old for COVID-19 immunisation. Patient had no COVID-19 prior vaccination. COVID-19 was not tested post vaccination. There was no known allergies. Other relevant medical history was reported as none. Concomitant medications were not reported. There was no other vaccine in four weeks. Patient had total paralysis of the left side of his face on 22Feb2021 at 07:00 AM. It was reported that the event resulted in disability or permanent damage. Outcome of the event was not recovered. No treatment for the event was received.  Information on the lot/batch number has been requested.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rhinorrhoea
Clinical narrative: had total paralysis of the left side of his face; This is a spontaneous report from a contactable consumer (Patient). A 61-year-old male patient received 2nd dose of BNT162B2  (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration at arm left on 20Feb2021 11:00 AM at the age of 61-year-old at single dose for COVID-19 immunisation. Patient previously received first dose of BNT162B2  (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration at left arm on 30Jan2021 11:00 AM at the age of 61-year-old for COVID-19 immunisation. Patient had no COVID-19 prior vaccination. COVID-19 was not tested post vaccination. There was no known allergies. Other relevant medical history was reported as none. Concomitant medications were not reported. There was no other vaccine in four weeks. Patient had total paralysis of the left side of his face on 22Feb2021 at 07:00 AM. It was reported that the event resulted in disability or permanent damage. Outcome of the event was not recovered. No treatment for the event was received.  Information on the lot/batch number has been requested.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Facial paralysis
Clinical narrative: had total paralysis of the left side of his face; This is a spontaneous report from a contactable consumer (Patient). A 61-year-old male patient received 2nd dose of BNT162B2  (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration at arm left on 20Feb2021 11:00 AM at the age of 61-year-old at single dose for COVID-19 immunisation. Patient previously received first dose of BNT162B2  (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration at left arm on 30Jan2021 11:00 AM at the age of 61-year-old for COVID-19 immunisation. Patient had no COVID-19 prior vaccination. COVID-19 was not tested post vaccination. There was no known allergies. Other relevant medical history was reported as none. Concomitant medications were not reported. There was no other vaccine in four weeks. Patient had total paralysis of the left side of his face on 22Feb2021 at 07:00 AM. It was reported that the event resulted in disability or permanent damage. Outcome of the event was not recovered. No treatment for the event was received.  Information on the lot/batch number has been requested.
Age: 62.0
Sex: M
Vaccine: UNK, VARZOS
Symptoms: Swelling of eyelid
Clinical narrative: Woke up  on 2/3/2021 and my right eye was blurry, with a lot of black spots floating around in my eye.  Went to my eye doctor on 2/4/2021 and he did a series of tests, he was said my pressure in my eye was high and recommend that I go to a retinal specialist.  I went a retinal specialist and he was not able to determine the problem and sent me to hospital.   The doctor said I had acute retinal necrosis.  I developed  the HSV-1 virus in my right eye.  The Doctor said it was maybe a  coincidence that it happen
Age: 62.0
Sex: M
Vaccine: UNK, VARZOS
Symptoms: Herpes simplex, Laboratory test, Necrotising retinitis, Ocular discomfort, Vision blurred
Clinical narrative: Woke up  on 2/3/2021 and my right eye was blurry, with a lot of black spots floating around in my eye.  Went to my eye doctor on 2/4/2021 and he did a series of tests, he was said my pressure in my eye was high and recommend that I go to a retinal specialist.  I went a retinal specialist and he was not able to determine the problem and sent me to hospital.   The doctor said I had acute retinal necrosis.  I developed  the HSV-1 virus in my right eye.  The Doctor said it was maybe a  coincidence that it happen
Age: 62.0
Sex: M
Vaccine: UNK, VARZOS
Symptoms: Vitreous floaters
Clinical narrative: Woke up  on 2/3/2021 and my right eye was blurry, with a lot of black spots floating around in my eye.  Went to my eye doctor on 2/4/2021 and he did a series of tests, he was said my pressure in my eye was high and recommend that I go to a retinal specialist.  I went a retinal specialist and he was not able to determine the problem and sent me to hospital.   The doctor said I had acute retinal necrosis.  I developed  the HSV-1 virus in my right eye.  The Doctor said it was maybe a  coincidence that it happen
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Blood count, Electrocardiogram, Ventricular tachycardia, X-ray
Clinical narrative: Initially with severely sore arm, headache, cough, chest tightness/congestion, and heartburn unrelieved by medication that began approx 24 hours after vaccination. Then, per patient: "Almost 2 weeks to the day after getting my first shot, on Friday 2/26, I suddenly and unexpectedly went into Rapid Ventricular Response atrial fibrillation. I was admitted to the ER department at Northwestern. I was there 10 hours and multiple tests were completed. At this time, no causes have been found that would have contributed to my going into RVR A-fib.  I am wearing a heart monitor for 2 weeks and will undergo a stress echo exam on my heart.  I do not have a cardiac history."
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Cardiac monitoring, Chest discomfort, Cough, Dyspepsia
Clinical narrative: Initially with severely sore arm, headache, cough, chest tightness/congestion, and heartburn unrelieved by medication that began approx 24 hours after vaccination. Then, per patient: "Almost 2 weeks to the day after getting my first shot, on Friday 2/26, I suddenly and unexpectedly went into Rapid Ventricular Response atrial fibrillation. I was admitted to the ER department at Northwestern. I was there 10 hours and multiple tests were completed. At this time, no causes have been found that would have contributed to my going into RVR A-fib.  I am wearing a heart monitor for 2 weeks and will undergo a stress echo exam on my heart.  I do not have a cardiac history."
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain in extremity, Pulmonary congestion
Clinical narrative: Initially with severely sore arm, headache, cough, chest tightness/congestion, and heartburn unrelieved by medication that began approx 24 hours after vaccination. Then, per patient: "Almost 2 weeks to the day after getting my first shot, on Friday 2/26, I suddenly and unexpectedly went into Rapid Ventricular Response atrial fibrillation. I was admitted to the ER department at Northwestern. I was there 10 hours and multiple tests were completed. At this time, no causes have been found that would have contributed to my going into RVR A-fib.  I am wearing a heart monitor for 2 weeks and will undergo a stress echo exam on my heart.  I do not have a cardiac history."
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Lymphadenopathy, Pain, Peripheral swelling, Somnolence
Clinical narrative: Patient is experiencing  left axillary lymph node to size of golf ball as well as swollen left arm. Left arm swelling and increasing by day. Started swelling at injection site and has now progressed to his whole arm.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site swelling, Lymphadenopathy, Peripheral swelling
Clinical narrative: Patient is experiencing  left axillary lymph node to size of golf ball as well as swollen left arm. Left arm swelling and increasing by day. Started swelling at injection site and has now progressed to his whole arm.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Report received from Health Dept that patient had reached out to them to report he had gotten Moderna COVID-19 vaccinations on 1/4/21 and 2/1/21, and began to experience L facial numbness and weakness on 2/25/21 AM with sudden onset.  He went to ED this day, given ASA and IV NS, underwent CT Angiogram of head&neck with contrast, and was transferred to Hospital.  Upon arrival to hospital, he continued to endorse numbness in his L check, lips and tongue.  On the day of patient discharge on 2/27/21, patient also noted R sided facial weakness.  He also has hx of COVID-19 in Oct 2020 with residual cough until Dec 2020.  He has surgical hx of C6-C7 fusion in 2018.  He also has had chronic neck pain which can radiate up to his head causing headache for months and has an appt to see his neurosurgeon for this issue. He also has a hx of herpes zoster on R face.  MRI of brain was negative for acute infarct or hemorrhage.  He was diagnosed with Bell's palsy and was started on prednisone 60 mg PO daily x7 days and valacyclovir 1000 mg PO TID x7 days.  COVID-19, COVID-19 vaccination, and VZV histories were considered by Neurology service at hospital, and Bell's palsy was thought to be idiosyncratic or related to VZV.  No allergies added to patient chart.  I am filing a VAERS report on 3/3/21 for completeness of investigation and response to this case.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging normal, Mobility decreased, Paraesthesia, Paraesthesia oral
Clinical narrative: Report received from Health Dept that patient had reached out to them to report he had gotten Moderna COVID-19 vaccinations on 1/4/21 and 2/1/21, and began to experience L facial numbness and weakness on 2/25/21 AM with sudden onset.  He went to ED this day, given ASA and IV NS, underwent CT Angiogram of head&neck with contrast, and was transferred to Hospital.  Upon arrival to hospital, he continued to endorse numbness in his L check, lips and tongue.  On the day of patient discharge on 2/27/21, patient also noted R sided facial weakness.  He also has hx of COVID-19 in Oct 2020 with residual cough until Dec 2020.  He has surgical hx of C6-C7 fusion in 2018.  He also has had chronic neck pain which can radiate up to his head causing headache for months and has an appt to see his neurosurgeon for this issue. He also has a hx of herpes zoster on R face.  MRI of brain was negative for acute infarct or hemorrhage.  He was diagnosed with Bell's palsy and was started on prednisone 60 mg PO daily x7 days and valacyclovir 1000 mg PO TID x7 days.  COVID-19, COVID-19 vaccination, and VZV histories were considered by Neurology service at hospital, and Bell's palsy was thought to be idiosyncratic or related to VZV.  No allergies added to patient chart.  I am filing a VAERS report on 3/3/21 for completeness of investigation and response to this case.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Arteriogram carotid abnormal, Bell's palsy, Facial paresis, Hypoaesthesia
Clinical narrative: Report received from Health Dept that patient had reached out to them to report he had gotten Moderna COVID-19 vaccinations on 1/4/21 and 2/1/21, and began to experience L facial numbness and weakness on 2/25/21 AM with sudden onset.  He went to ED this day, given ASA and IV NS, underwent CT Angiogram of head&neck with contrast, and was transferred to Hospital.  Upon arrival to hospital, he continued to endorse numbness in his L check, lips and tongue.  On the day of patient discharge on 2/27/21, patient also noted R sided facial weakness.  He also has hx of COVID-19 in Oct 2020 with residual cough until Dec 2020.  He has surgical hx of C6-C7 fusion in 2018.  He also has had chronic neck pain which can radiate up to his head causing headache for months and has an appt to see his neurosurgeon for this issue. He also has a hx of herpes zoster on R face.  MRI of brain was negative for acute infarct or hemorrhage.  He was diagnosed with Bell's palsy and was started on prednisone 60 mg PO daily x7 days and valacyclovir 1000 mg PO TID x7 days.  COVID-19, COVID-19 vaccination, and VZV histories were considered by Neurology service at hospital, and Bell's palsy was thought to be idiosyncratic or related to VZV.  No allergies added to patient chart.  I am filing a VAERS report on 3/3/21 for completeness of investigation and response to this case.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia oral, Magnetic resonance imaging head normal, Scan with contrast
Clinical narrative: Report received from Health Dept that patient had reached out to them to report he had gotten Moderna COVID-19 vaccinations on 1/4/21 and 2/1/21, and began to experience L facial numbness and weakness on 2/25/21 AM with sudden onset.  He went to ED this day, given ASA and IV NS, underwent CT Angiogram of head&neck with contrast, and was transferred to Hospital.  Upon arrival to hospital, he continued to endorse numbness in his L check, lips and tongue.  On the day of patient discharge on 2/27/21, patient also noted R sided facial weakness.  He also has hx of COVID-19 in Oct 2020 with residual cough until Dec 2020.  He has surgical hx of C6-C7 fusion in 2018.  He also has had chronic neck pain which can radiate up to his head causing headache for months and has an appt to see his neurosurgeon for this issue. He also has a hx of herpes zoster on R face.  MRI of brain was negative for acute infarct or hemorrhage.  He was diagnosed with Bell's palsy and was started on prednisone 60 mg PO daily x7 days and valacyclovir 1000 mg PO TID x7 days.  COVID-19, COVID-19 vaccination, and VZV histories were considered by Neurology service at hospital, and Bell's palsy was thought to be idiosyncratic or related to VZV.  No allergies added to patient chart.  I am filing a VAERS report on 3/3/21 for completeness of investigation and response to this case.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Epistaxis, Petechiae, Thrombocytopenia
Clinical narrative: The patient is a 65 y.o. female who was transferred here from ED due to thrombocytopenia. She reports she had her first COVID vaccine on Friday 2/26/21. Saturday she began to have intermittent nose bleeds. She notes it would gush out, then she could get it stopped. This has gotten progressively worse, she has clamp on her nose presently. When it was removed in ED, she started bleeding again pretty quickly. Sunday 2/28/21 she noticed blood blisters in her mouth. They are 2-4mm in diameter, except for a large on the left corner of her mouth. She denies pain or bleeding from these. Today, 3/1/21 she noted pink rash on her bilateral legs and due to nose bleeding worsening she went to ED. She has never had this problem before. She states a couple years ago her PCP told her she had low PLT, but on recheck they were normal again. She had labs about 1 month ago and notes they were normal, however she is not sure what was drawn. I do not have access to those records at this time. No family history of bleeding disorders or cancer. None for herself either. She has HTN, hypothyroid, and Hyperlipidemia. She was given 10mg IV dexamethasone in ED prior to transfer. She is alert, oriented, and pleasant. She denies pain, nausea, vomiting, diarrhea, fever, chills, malaise, cough, shortness of breath, or chest pain. Hematology consulted due to thrombocytopenia.  Admitted and treated with IVIG, dexamethasone, plt transfusions
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Epistaxis, Haemoglobin decreased, Immunoglobulin therapy, Oral blood blister, Platelet count decreased
Clinical narrative: The patient is a 65 y.o. female who was transferred here from ED due to thrombocytopenia. She reports she had her first COVID vaccine on Friday 2/26/21. Saturday she began to have intermittent nose bleeds. She notes it would gush out, then she could get it stopped. This has gotten progressively worse, she has clamp on her nose presently. When it was removed in ED, she started bleeding again pretty quickly. Sunday 2/28/21 she noticed blood blisters in her mouth. They are 2-4mm in diameter, except for a large on the left corner of her mouth. She denies pain or bleeding from these. Today, 3/1/21 she noted pink rash on her bilateral legs and due to nose bleeding worsening she went to ED. She has never had this problem before. She states a couple years ago her PCP told her she had low PLT, but on recheck they were normal again. She had labs about 1 month ago and notes they were normal, however she is not sure what was drawn. I do not have access to those records at this time. No family history of bleeding disorders or cancer. None for herself either. She has HTN, hypothyroid, and Hyperlipidemia. She was given 10mg IV dexamethasone in ED prior to transfer. She is alert, oriented, and pleasant. She denies pain, nausea, vomiting, diarrhea, fever, chills, malaise, cough, shortness of breath, or chest pain. Hematology consulted due to thrombocytopenia.  Admitted and treated with IVIG, dexamethasone, plt transfusions
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Platelet transfusion, Rash, Rash erythematous, Thrombocytopenia
Clinical narrative: The patient is a 65 y.o. female who was transferred here from ED due to thrombocytopenia. She reports she had her first COVID vaccine on Friday 2/26/21. Saturday she began to have intermittent nose bleeds. She notes it would gush out, then she could get it stopped. This has gotten progressively worse, she has clamp on her nose presently. When it was removed in ED, she started bleeding again pretty quickly. Sunday 2/28/21 she noticed blood blisters in her mouth. They are 2-4mm in diameter, except for a large on the left corner of her mouth. She denies pain or bleeding from these. Today, 3/1/21 she noted pink rash on her bilateral legs and due to nose bleeding worsening she went to ED. She has never had this problem before. She states a couple years ago her PCP told her she had low PLT, but on recheck they were normal again. She had labs about 1 month ago and notes they were normal, however she is not sure what was drawn. I do not have access to those records at this time. No family history of bleeding disorders or cancer. None for herself either. She has HTN, hypothyroid, and Hyperlipidemia. She was given 10mg IV dexamethasone in ED prior to transfer. She is alert, oriented, and pleasant. She denies pain, nausea, vomiting, diarrhea, fever, chills, malaise, cough, shortness of breath, or chest pain. Hematology consulted due to thrombocytopenia.  Admitted and treated with IVIG, dexamethasone, plt transfusions
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Asthenia, Fatigue, Flushing, Headache
Clinical narrative: Patient described the event as "severe anaphylaxis" that included redness all over the body and a rash on the face, with a strange feeling in the esophagus but no trouble breathing. The patient self-medicated with prednisone and did not seek medical care. Symptoms resolved later the same day they appeared. The patient indicated he had an appointment unrelated to this event scheduled with his primary care physician on March 3, 2021, and was advised to discuss the reaction with the physician at this appointment.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rash
Clinical narrative: Patient described the event as "severe anaphylaxis" that included redness all over the body and a rash on the face, with a strange feeling in the esophagus but no trouble breathing. The patient self-medicated with prednisone and did not seek medical care. Symptoms resolved later the same day they appeared. The patient indicated he had an appointment unrelated to this event scheduled with his primary care physician on March 3, 2021, and was advised to discuss the reaction with the physician at this appointment.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Asthenia, Blood pressure decreased, Blood pressure measurement, Body temperature
Clinical narrative: Patient described the event as "severe anaphylaxis" that included redness all over the body and a rash on the face, with a strange feeling in the esophagus but no trouble breathing. The patient self-medicated with prednisone and did not seek medical care. Symptoms resolved later the same day they appeared. The patient indicated he had an appointment unrelated to this event scheduled with his primary care physician on March 3, 2021, and was advised to discuss the reaction with the physician at this appointment.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Fatigue, Heart rate, Rash erythematous
Clinical narrative: Patient described the event as "severe anaphylaxis" that included redness all over the body and a rash on the face, with a strange feeling in the esophagus but no trouble breathing. The patient self-medicated with prednisone and did not seek medical care. Symptoms resolved later the same day they appeared. The patient indicated he had an appointment unrelated to this event scheduled with his primary care physician on March 3, 2021, and was advised to discuss the reaction with the physician at this appointment.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Erythema, Feeling abnormal, Rash
Clinical narrative: Patient described the event as "severe anaphylaxis" that included redness all over the body and a rash on the face, with a strange feeling in the esophagus but no trouble breathing. The patient self-medicated with prednisone and did not seek medical care. Symptoms resolved later the same day they appeared. The patient indicated he had an appointment unrelated to this event scheduled with his primary care physician on March 3, 2021, and was advised to discuss the reaction with the physician at this appointment.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: Allergic reaction:  About 5 minutes after the shot I started feeling flush and I turned blotchy red on my face, neck, chest, and arms. That flushing was followed quickly by mild shortness of breath, an overwhelming feeling of being so hot, a heavy-headed feeling, chest tightness, face and scalp tingling, confusion, hand tremors, and tightness in my throat. This all started during the 15-minute observation period. I raised my hand to report my symptoms, and the onsite nurses took me to a private area to monitor me. My heart rate was quite high (tachycardia) and my blood pressure was very elevated at 184/116. They gave me 50mg of benadryl and continued to check my heart rate and blood pressure. After 30 more minutes, my vitals still weren't really improving nor were my other symptoms, so the decision was made to call paramedics and have me transported to the emergency department for further evaluation/observation. After 30mg zyrtec, 50mg benadryl, 40mg famotidine, and 3 hours, I was feeling much better. My blood pressure was still elevated and my pulse pressure was quite wide, but my heart rate and other symptoms were improved so I was discharged to home, where I pretty quickly fell into a 3-hour deep slumber. I awoke still feeling shakey and confused. The confusion continued throughout the next day. It has finally subsided on day 3.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Chest discomfort, Confusional state, Dyspnoea, Electrocardiogram normal
Clinical narrative: Allergic reaction:  About 5 minutes after the shot I started feeling flush and I turned blotchy red on my face, neck, chest, and arms. That flushing was followed quickly by mild shortness of breath, an overwhelming feeling of being so hot, a heavy-headed feeling, chest tightness, face and scalp tingling, confusion, hand tremors, and tightness in my throat. This all started during the 15-minute observation period. I raised my hand to report my symptoms, and the onsite nurses took me to a private area to monitor me. My heart rate was quite high (tachycardia) and my blood pressure was very elevated at 184/116. They gave me 50mg of benadryl and continued to check my heart rate and blood pressure. After 30 more minutes, my vitals still weren't really improving nor were my other symptoms, so the decision was made to call paramedics and have me transported to the emergency department for further evaluation/observation. After 30mg zyrtec, 50mg benadryl, 40mg famotidine, and 3 hours, I was feeling much better. My blood pressure was still elevated and my pulse pressure was quite wide, but my heart rate and other symptoms were improved so I was discharged to home, where I pretty quickly fell into a 3-hour deep slumber. I awoke still feeling shakey and confused. The confusion continued throughout the next day. It has finally subsided on day 3.